Stockscreener 앱 받기
2.08
3.48%
0.07
전일 마감가:
$2.01
열려 있는:
$1.99
하루 거래량:
788.22K
Relative Volume:
1.25
시가총액:
$158.49M
수익:
$151.64M
순이익/손실:
$-37.23M
주가수익비율:
-3.8067
EPS:
-0.5464
순현금흐름:
$-13.58M
1주 성능:
+10.34%
1개월 성능:
-27.78%
6개월 성능:
+23.08%
1년 성능:
-29.73%
1일 변동 폭
$0.00
$0.00
1주일 범위
$1.85
$2.105
52주 변동 폭
$0.80
$3.44
Neuronetics Inc Stock (STIM) Company Profile
명칭
Neuronetics Inc
전화
877-600-7555
주소
3222 PHOENIXVILLE PIKE, MALVERN, PA
Compare STIM vs ABT, MDT, SYK, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
STIM
Neuronetics Inc
|
2.08 | 158.49M | 151.64M | -37.23M | -13.58M | -0.5464 |
ABT
Abbott Laboratories
|
102.51 | 177.38B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
96.59 | 123.55B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
307.08 | 117.79B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
46.01 | 66.68B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.09 | 51.93B | 6.30B | 1.07B | 1.09B | 1.8406 |
Neuronetics Inc Stock (STIM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-09-11 | 개시 | B. Riley Securities | Buy |
| 2026-07-20 | 개시 | BTIG Research | Buy |
| 2024-08-13 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-10-13 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2021-10-13 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-01-22 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2020-02-06 | 개시 | BTIG Research | Buy |
| 2018-07-24 | 개시 | Canaccord Genuity | Buy |
모두보기
Neuronetics Inc 주식(STIM)의 최신 뉴스
Integra LifeSciences (IART) Surpasses Q3 Earnings Estimates - Zacks Investment Research
Neuronetics (NasdaqGM:STIM) Stock Forecast & Analyst Predictions - Simply Wall Street
STIM Looks 73.9% Overvalued on GF Value™ - GuruFocus
Neuronetics a new buy at B Riley on interventional psychiatry platform - Seeking Alpha
STIM Initiated Coverage On by B. Riley Securities -- Rating Set to Buy - GuruFocus
Neuronetics stock gains after B.Riley initiates coverage at Buy By Investing.com - Investing.com South Africa
Neuronetics stock gains after B.Riley initiates coverage at Buy - investing.com
B.Riley initiates Neuronetics stock coverage with buy rating - investing.com
NeuroStar Advances Practice Innovation with First-Ever TMS Integration with an EHR/EMR System - Investing News Network
Neuronetics, Inc. Integrates TrakStar With AdvancedMD, Inc. To Deliver TMS Care Across Clinical, Operational, And Billing Workflows - marketscreener.com
A magnetic brain-treatment system links to patient records for the first time - Stock Titan
Neuronetics (STIM) Slips 2.46% to $2.77 as Key Support LoomsSystematic Flow - vinanet.vn
Neuronetics (NASDAQ: STIM) backer spent about $20.7M of his own cash - Stock Titan
Neuronetics (STIM) Results Breakdown: The Available Earnings Metric Delivers a Beat in the Current Update; After Results: The Market Price Declines 1.59% in Latest TradingEarnings Miss Streak - vinanet.vn
Neuronetics (NASDAQ: STIM) ex-officer lines up $464K stock sale - Stock Titan
Neuronetics | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
Neuronetics Expands CFO Nir Naor’s Financial Leadership Role - The Globe and Mail
Neuronetics (NASDAQ: STIM) holder plans $388K sale with part for taxes - Stock Titan
Neuronetics (STIM) Q2 2026 Earnings Call Transcript - AOL.com
Neuronetics (STIM) Q2 2026 Earnings Call Transcript - The Globe and Mail
Neuronetics (STIM) Edges Lower by 0.91% as Shares Navigate Key Support at $3.11Volume Weighted Price - vinanet.vn
Neuronetics (STIM) Slips to $3.25 as Shares Hover Near Key SupportPairs Trade - vinanet.vn
Neuronetics (NASDAQ:STIM) Major Shareholder Buys $44,240.00 in Stock - MarketBeat
Neuronetics director Jorey Chernett buys $44,240 in company stock - Investing.com
Neuronetics director Jorey Chernett buys $44,240 in company stock By Investing.com - Investing.com Canada
Neuronetics 10% owner Jorey Chernett acquires 14,000 common shares worth $44,240 - Bitget
Neuronetics (STIM) 10% holder buys stock, exits call options - Stock Titan
Neuronetics | 4: Statement of changes in beneficial ownership of securities-10% Owner Chernett Jorey - Moomoo
Neuronetics Stock Price Forecast. Should You Buy STIM? - StockInvest.us
Point72 discloses 5% Neuronetics (STIM) stake in new SEC ownership filing - Stock Titan
US$6.00That's What Analysts Think Neuronetics, Inc. (NASDAQ:STIM) Is Worth After These Results - simplywall.st
Neuronetics Q2 2026 Results: Hybrid NeuroStar Model and Greenbrook Growth Signal Strategic PivotEarnings Preview - Vinanet
Neuronetics earnings beat by $0.07, revenue topped estimates - Investing.com Nigeria
Neuronetics (STIM) Stock Repriced After Margin Gains And EBITDA Breakeven - Sahm
Neuronetics earnings beat by $0.07, revenue topped estimates - Investing.com Canada
Neuronetics, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Neuronetics Inc (STIM) (Q2 2026) Earnings Call Highlights: Reven - GuruFocus
Neuronetics Inc (STIM) (Q2 2026) Earnings Call Highlights: Revenue Growth and Margin Expansion ... - Yahoo Finance
Neuronetics (STIM) grows sales as going concern risk emerges under debt covenants - Stock Titan
STIM Maintained by BTIG -- Price Target Raised to $6.00 - GuruFocus
Neuronetics stock price target raised to $6 by BTIG on profitability - Investing.com Nigeria
Neuronetics stock price target raised to $6 by BTIG on profitability - Investing.com
Neuronetics stock price target raised to $6 by BTIG on profitability - Investing.com Canada
Earnings call transcript: Neuronetics tops Q2 2026 forecasts as stock jumps 23% - Investing.com Canada
BTIG Research Forecasts Strong Price Appreciation for Neuronetics (NASDAQ:STIM) Stock - MarketBeat
Earnings call transcript: Neuronetics tops Q2 2026 forecasts as stock jumps 23% - Investing.com UK
Neuronetics Q2 2026 slides: mental health platform beats on margins By Investing.com - Investing.com Canada
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Earnings call transcript: Neuronetics tops Q2 2026 forecasts as stock jumps 23% - Investing.com Australia
Neuronetics Q2 Earnings Call Highlights - MarketBeat
Neuronetics Inc (STIM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Neuronetics Inc 주식 (STIM) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| MACAN WILLIAM ANDREW | Officer |
Aug 18 '26 |
Proposed Sale |
3.21 |
121,033 |
388,274 |
0 |
| Chernett Jorey | 10% Owner |
Aug 14 '26 |
Buy |
3.16 |
14,000 |
44,240 |
10,602,988 |
| Chernett Jorey | 10% Owner |
Jul 14 '26 |
Buy |
1.78 |
35,000 |
62,300 |
10,588,988 |
| Sullivan Keith J | Former Officer and Director |
Jun 08 '26 |
Proposed Sale |
1.29 |
42,164 |
54,345 |
0 |
| Chernett Jorey | 10% Owner |
May 19 '26 |
Buy |
1.17 |
100,000 |
117,000 |
10,553,988 |
| Chernett Jorey | 10% Owner |
May 12 '26 |
Buy |
1.34 |
475,000 |
636,500 |
10,453,988 |
| Chernett Jorey | 10% Owner |
Apr 21 '26 |
Buy |
1.51 |
100,000 |
151,000 |
9,978,988 |
| Chernett Jorey | 10% Owner |
Apr 20 '26 |
Buy |
1.58 |
100,000 |
158,000 |
9,878,988 |
| Chernett Jorey | 10% Owner |
Mar 30 '26 |
Buy |
1.25 |
385,442 |
481,802 |
9,778,988 |
| Chernett Jorey | 10% Owner |
Mar 27 '26 |
Buy |
1.35 |
500,000 |
675,000 |
9,393,276 |
2.72%
1.79%
자본화:
|
볼륨(24시간):